{"id":606,"date":"2026-02-28T13:14:16","date_gmt":"2026-02-28T13:14:16","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/minoca-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T13:14:16","modified_gmt":"2026-02-28T13:14:16","slug":"minoca-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/minoca-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"MINOCA: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">MINOCA Introduction (What it is)<\/h2>\n\n\n\n<p>MINOCA stands for <strong>myocardial infarction with non-obstructive coronary arteries<\/strong>.<br\/>\nIt is a <strong>clinical syndrome (working diagnosis)<\/strong> that looks like a heart attack but lacks a major coronary blockage on angiography.<br\/>\nMINOCA is commonly encountered in <strong>acute coronary syndrome<\/strong> pathways in emergency and inpatient cardiology.<br\/>\nIt prompts clinicians to look for <strong>alternative coronary and non-coronary mechanisms<\/strong> of myocardial (heart muscle) injury.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why MINOCA matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>MINOCA matters because it sits at the intersection of \u201cclassic\u201d myocardial infarction (MI) care and a broad differential diagnosis of myocardial injury. Patients present with symptoms, electrocardiogram (ECG) findings, and biomarker patterns that often trigger standard MI protocols, yet coronary angiography does not show an obstructive culprit stenosis. This can create uncertainty about diagnosis, risk, and treatment.<\/p>\n\n\n\n<p>From an education standpoint, MINOCA is a practical framework for learning how to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Apply the <strong>Universal Definition of MI<\/strong> (ischemic myocardial injury) versus <strong>non-ischemic myocardial injury<\/strong>.<\/li>\n<li>Interpret coronary angiography beyond \u201cblocked or not blocked,\u201d including <strong>plaque disruption<\/strong>, <strong>spasm<\/strong>, <strong>microvascular dysfunction<\/strong>, and <strong>embolism<\/strong>.<\/li>\n<li>Use targeted testing (for example, <strong>cardiac magnetic resonance imaging<\/strong>, CMR) to identify a specific etiology that guides management.<\/li>\n<\/ul>\n\n\n\n<p>Clinically, MINOCA is important because the <strong>underlying cause drives prognosis and therapy<\/strong>. A patient with coronary vasospasm, spontaneous coronary artery dissection, myocarditis, or stress (Takotsubo) cardiomyopathy may look similar on presentation but may follow different care pathways. Clear diagnostic labeling also supports appropriate follow-up, patient counseling, and rehabilitation planning in general terms.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>MINOCA is not a single disease. It is an umbrella term used after angiography shows <strong>non-obstructive coronary arteries<\/strong> in a patient meeting criteria for MI. Classification is typically based on the <strong>underlying mechanism<\/strong>, which may be coronary (ischemic) or non-coronary (myocardial injury that mimics MI).<\/p>\n\n\n\n<p>A practical way to categorize MINOCA is:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1) Coronary (ischemic) mechanisms consistent with MI<\/h3>\n\n\n\n<p>These are causes where myocardial infarction occurs despite the absence of a large fixed obstruction:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Plaque disruption without obstructive stenosis<\/strong><br\/>\n  Examples include plaque rupture, erosion, or calcified nodules with transient thrombosis.<\/p>\n<\/li>\n<li>\n<p><strong>Coronary vasospasm (epicardial spasm)<\/strong><br\/>\n  Transient constriction of a coronary artery reduces blood flow.<\/p>\n<\/li>\n<li>\n<p><strong>Coronary microvascular dysfunction<\/strong><br\/>\n  Abnormalities in small intramyocardial vessels impair perfusion even when large vessels look normal.<\/p>\n<\/li>\n<li>\n<p><strong>Coronary thromboembolism<\/strong><br\/>\n  Clot formation or embolization to a coronary artery (for example, from atrial fibrillation or valve disease).<\/p>\n<\/li>\n<li>\n<p><strong>Spontaneous coronary artery dissection (SCAD)<\/strong><br\/>\n  A tear or intramural hematoma narrows the lumen and reduces flow; angiographic appearance can be subtle.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2) Non-coronary conditions that can mimic MI (important alternatives)<\/h3>\n\n\n\n<p>Some conditions produce chest pain and troponin rise but are not classic ischemic MI:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Myocarditis<\/strong> (inflammatory myocardial injury)<\/li>\n<li><strong>Takotsubo (stress) cardiomyopathy<\/strong> (transient ventricular dysfunction triggered by stressors)<\/li>\n<li><strong>Other causes of myocardial injury<\/strong> (for example, severe supply\u2013demand mismatch in systemic illness)<\/li>\n<\/ul>\n\n\n\n<p>Whether these are labeled \u201cMINOCA\u201d can vary by clinician and case. Many clinicians treat MINOCA as a <em>working diagnosis<\/em> pending additional imaging (especially CMR) to separate ischemic MI from non-ischemic injury.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding MINOCA starts with how the heart muscle receives oxygen and how ischemia develops.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Coronary circulation (macro- and microvasculature)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The <strong>right coronary artery (RCA)<\/strong> and <strong>left coronary system<\/strong> (left anterior descending, LAD; left circumflex, LCx) supply oxygenated blood to the myocardium.<\/li>\n<li><strong>Epicardial coronary arteries<\/strong> are the larger surface vessels visualized on coronary angiography.<\/li>\n<li><strong>Microvascular circulation<\/strong> (arterioles and capillaries within the myocardium) regulates local blood flow; it is not directly seen on routine angiography but strongly influences perfusion.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Myocardial oxygen supply and demand<\/h3>\n\n\n\n<p>Ischemia occurs when oxygen supply cannot meet myocardial demand. In MINOCA, supply can be reduced without a fixed obstructive plaque, for example by:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>transient spasm,<\/li>\n<li>microvascular constriction or dysfunction,<\/li>\n<li>transient thrombosis or embolus,<\/li>\n<li>dissection causing dynamic narrowing.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Biomarkers and myocardial injury<\/h3>\n\n\n\n<p><strong>Cardiac troponins<\/strong> are released when cardiomyocytes are injured. Troponin rise indicates myocardial injury but does not, by itself, specify the cause. Clinicians integrate:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>symptoms (for example, chest pressure),<\/li>\n<li>ECG changes (ST-segment changes, T-wave inversions),<\/li>\n<li>imaging evidence of new loss of viable myocardium or wall-motion abnormality,<\/li>\n<\/ul>\n\n\n\n<p>to decide whether injury is <strong>ischemic MI<\/strong> or a non-ischemic process.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>MINOCA mechanisms are heterogeneous, and the \u201csame\u201d presentation can result from different pathophysiology. Key mechanisms include:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Plaque disruption with non-obstructive disease<\/h3>\n\n\n\n<p>A coronary plaque can rupture or erode without leaving a persistent severe narrowing. A thrombus may form and then partially lyse or migrate, leaving a non-obstructive angiogram. Despite the absence of a large residual blockage, downstream myocardium may suffer infarction.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Coronary vasospasm<\/h3>\n\n\n\n<p>Vasospasm is hyperreactivity of coronary smooth muscle causing intense transient constriction. This can reduce blood flow enough to cause ischemia, ECG changes, and troponin rise. Triggers and susceptibility vary by patient factors and protocol.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Microvascular dysfunction<\/h3>\n\n\n\n<p>In microvascular dysfunction, the small intramyocardial vessels do not dilate appropriately, may constrict abnormally, or have endothelial dysfunction. Even with open epicardial arteries, inadequate microvascular perfusion can cause ischemia.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Coronary thromboembolism<\/h3>\n\n\n\n<p>A thrombus may form within a coronary artery or embolize from elsewhere. Potential contributors include arrhythmias (for example, atrial fibrillation), cardiomyopathy with ventricular thrombus, valvular disease, or hypercoagulable states. The degree of occlusion may be partial or transient.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Spontaneous coronary artery dissection (SCAD)<\/h3>\n\n\n\n<p>SCAD involves separation of arterial wall layers with an intramural hematoma that compresses the lumen. It may produce a subtle angiographic appearance and can be missed without careful review or intravascular imaging in selected cases.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Non-ischemic injury mimics<\/h3>\n\n\n\n<p>Myocarditis reflects inflammation and myocyte injury, while Takotsubo cardiomyopathy involves transient myocardial stunning often associated with catecholamine surges. Both can present like MI yet differ in tissue characteristics and management considerations.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>MINOCA is typically recognized when a patient presents like an acute MI but angiography shows non-obstructive coronary arteries. Common scenarios include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Chest discomfort consistent with acute coronary syndrome (pressure, tightness, or pain)<\/li>\n<li>Shortness of breath, diaphoresis, nausea, or unexplained fatigue<\/li>\n<li>ECG findings suggestive of ischemia (ST-segment elevation or depression, T-wave inversions) or sometimes non-specific changes<\/li>\n<li>Elevated cardiac troponin with a rise\/fall pattern consistent with acute injury<\/li>\n<li>Regional wall-motion abnormality on echocardiography without an obstructive culprit lesion on angiography<\/li>\n<li>A clinical context suggesting alternative mechanisms (for example, episodes at rest for vasospasm, recent stressor for Takotsubo, or prothrombotic risk factors for embolism)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>MINOCA evaluation aims to confirm that the presentation meets criteria for MI and then identify the specific cause. Many clinicians approach MINOCA as a <em>diagnostic pathway<\/em> rather than an endpoint.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Step 1: Confirm acute myocardial infarction versus other injury<\/h3>\n\n\n\n<p>Clinicians typically integrate:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and exam<\/strong>: symptom characteristics, triggers, risk factors, systemic illness<\/li>\n<li><strong>ECG<\/strong>: ischemic patterns versus non-specific changes<\/li>\n<li><strong>Troponin pattern<\/strong>: rise\/fall consistent with acute injury (not just a single value)<\/li>\n<li><strong>Echocardiography<\/strong>: regional wall-motion abnormality, ventricular function, alternative diagnoses<\/li>\n<\/ul>\n\n\n\n<p>A key interpretive point: <strong>troponin elevation is not synonymous with MI<\/strong>. The diagnosis of MI requires evidence of ischemia, not solely biomarker release.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Step 2: Coronary angiography review (what \u201cnon-obstructive\u201d means)<\/h3>\n\n\n\n<p>MINOCA is considered when angiography does not show an obstructive stenosis suitable as a clear culprit. Interpretation can be nuanced:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mild-to-moderate atherosclerosis may still be present.<\/li>\n<li>Dynamic processes (spasm, thrombus that has resolved, SCAD) may not appear as a fixed obstruction.<\/li>\n<li>Angiographic appearance can be limited by image quality and vessel overlap.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Step 3: Identify the mechanism (targeted testing)<\/h3>\n\n\n\n<p>Common tools include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Cardiac magnetic resonance (CMR)<\/strong><br\/>\n  CMR can assess ventricular function, edema, and scar patterns (late gadolinium enhancement) that help distinguish ischemic infarction from myocarditis or Takotsubo cardiomyopathy.<\/p>\n<\/li>\n<li>\n<p><strong>Intravascular imaging (OCT\/IVUS)<\/strong> in selected cases<br\/>\n  Optical coherence tomography (OCT) and intravascular ultrasound (IVUS) can detect plaque disruption or SCAD not obvious on angiography. Use varies by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Coronary functional testing<\/strong> in selected cases<br\/>\n  Provocative testing for vasospasm and assessment of microvascular function may be considered in appropriate settings; availability and approach vary by center.<\/p>\n<\/li>\n<li>\n<p><strong>Laboratory and systemic evaluation<\/strong> when embolic or systemic causes are suspected<br\/>\n  This may include rhythm assessment, echocardiography for intracardiac thrombus or valve disease, and selective evaluation for prothrombotic conditions based on clinical context.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<p>A useful teaching point: the goal is to move from \u201cMINOCA\u201d to a <strong>specific diagnosis<\/strong> (for example, vasospastic angina causing MI, SCAD-related MI, myocarditis), because downstream management differs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management of MINOCA is <strong>etiology-driven<\/strong>. Because MINOCA is heterogeneous, treatment plans vary by clinician and case, and by the final diagnosis after testing.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">General principles<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Treat the presentation initially as an acute coronary syndrome while evaluation is underway, when clinically appropriate.<\/li>\n<li>Clarify the mechanism with targeted imaging and testing when feasible.<\/li>\n<li>Match therapies to the underlying cause rather than applying a single uniform regimen to all MINOCA patients.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Examples of mechanism-directed management concepts (non-prescriptive)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Plaque disruption-related MINOCA<\/strong>: may be approached similarly to atherosclerotic MI, emphasizing cardiovascular risk reduction and secondary prevention strategies in general terms.<\/li>\n<li><strong>Coronary vasospasm<\/strong>: management often focuses on vasomotor stabilization and trigger avoidance strategies; specific medication choices vary.<\/li>\n<li><strong>Microvascular dysfunction<\/strong>: management may emphasize symptom control and risk-factor optimization; response can be variable.<\/li>\n<li><strong>SCAD<\/strong>: many cases are managed conservatively with close follow-up; revascularization decisions depend on anatomy, stability, and flow.<\/li>\n<li><strong>Coronary thromboembolism<\/strong>: clinicians may look for and treat the embolic source; antithrombotic strategy depends on the suspected mechanism and bleeding risk.<\/li>\n<li><strong>Myocarditis or Takotsubo cardiomyopathy<\/strong>: management typically follows condition-specific pathways (supportive care, treating complications, and addressing triggers), rather than standard MI therapy.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Rehabilitation and education<\/h3>\n\n\n\n<p>Cardiac rehabilitation, lifestyle risk-factor modification, and return-to-activity planning may be discussed similarly to other acute cardiac events, but the details depend on diagnosis, ventricular function, symptoms, and clinician assessment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>MINOCA carries risks related to both the acute event and the underlying mechanism. Common considerations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Recurrent chest pain<\/strong> due to persistent vasospasm or microvascular dysfunction<\/li>\n<li><strong>Recurrent ischemic events<\/strong> if plaque disruption or thromboembolism is ongoing<\/li>\n<li><strong>Arrhythmias<\/strong> after myocardial injury (risk varies with infarct size, location, and ventricular function)<\/li>\n<li><strong>Heart failure<\/strong> if there is significant myocardial damage or stress cardiomyopathy with reduced function<\/li>\n<li><strong>Diagnostic limitations<\/strong> <\/li>\n<li>Angiography can miss plaque disruption, small-vessel disease, or subtle SCAD.  <\/li>\n<li>CMR timing and image quality can affect sensitivity for myocarditis or infarction patterns.  <\/li>\n<li>Functional coronary testing is not universally available and may not be appropriate for all patients.<\/li>\n<li><strong>Treatment trade-offs<\/strong><br\/>\n  Antithrombotic and other cardiovascular therapies may carry bleeding or hemodynamic risks, and appropriateness depends on the mechanism and patient factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis after MINOCA is variable because MINOCA is a <strong>syndrome with multiple etiologies<\/strong>. Outcomes depend on factors such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the underlying mechanism (for example, plaque disruption vs myocarditis vs SCAD),<\/li>\n<li>the extent and location of myocardial injury,<\/li>\n<li>left ventricular function and presence of heart failure,<\/li>\n<li>arrhythmia burden,<\/li>\n<li>comorbidities (for example, hypertension, diabetes, chronic kidney disease),<\/li>\n<li>success in identifying and addressing triggers or systemic contributors.<\/li>\n<\/ul>\n\n\n\n<p>Follow-up commonly focuses on confirming the final diagnosis, reassessing symptoms and functional status, monitoring ventricular recovery when relevant, and optimizing cardiovascular risk factors. The intensity and timing of follow-up vary by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">MINOCA Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does MINOCA actually mean in plain language?<\/strong><br\/>\nMINOCA means someone appears to have had a heart attack based on symptoms, ECG, and troponin testing, but the coronary angiogram does not show a major blocked artery. It is a working diagnosis that signals the need to look for less obvious coronary causes or non-coronary conditions that mimic MI.<\/p>\n\n\n\n<p><strong>Q: Is MINOCA \u201cnot a real heart attack\u201d?<\/strong><br\/>\nMINOCA can represent a true myocardial infarction, depending on whether the injury is ischemic and meets MI criteria. In other cases, the presentation is due to non-ischemic myocardial injury such as myocarditis or stress cardiomyopathy, which can look similar early on. Additional testing (often CMR) helps clarify this.<\/p>\n\n\n\n<p><strong>Q: How can someone have an MI without a big blockage?<\/strong><br\/>\nA large fixed blockage is one way to reduce blood flow, but it is not the only way. Transient clotting, plaque disruption with partial obstruction, coronary spasm, microvascular dysfunction, emboli, or SCAD can all reduce perfusion enough to injure the myocardium even if the angiogram looks \u201cnon-obstructive.\u201d<\/p>\n\n\n\n<p><strong>Q: What tests are commonly used after MINOCA is suspected?<\/strong><br\/>\nClinicians often reassess the ECG and echocardiogram, review angiography carefully, and consider CMR to distinguish ischemic infarction from myocarditis or Takotsubo cardiomyopathy. In selected settings, intravascular imaging (OCT\/IVUS) or coronary functional testing may be used to evaluate plaque disruption, SCAD, spasm, or microvascular disease. The exact sequence varies by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: Does MINOCA change the medications a patient might receive?<\/strong><br\/>\nIt can. Because MINOCA includes multiple mechanisms, clinicians generally try to tailor therapy to the cause (for example, vasospasm-focused therapy vs atherosclerosis-focused secondary prevention). When the cause is uncertain, short-term management may resemble acute coronary syndrome care while evaluation continues, but longer-term plans are typically refined once the diagnosis is clearer.<\/p>\n\n\n\n<p><strong>Q: Is the prognosis after MINOCA generally favorable?<\/strong><br\/>\nPrognosis varies. Some etiologies are associated with recovery of function (for example, some cases of stress cardiomyopathy), while others can have ongoing risk of recurrent ischemia or complications. The extent of myocardial injury and left ventricular function are important influences on outcomes.<\/p>\n\n\n\n<p><strong>Q: What does \u201cnon-obstructive coronary arteries\u201d mean on angiography?<\/strong><br\/>\nIt means angiography did not show a flow-limiting stenosis that clearly explains the MI presentation. Mild or moderate atherosclerosis may still be present, and some important causes (microvascular dysfunction, spasm, subtle plaque disruption, SCAD) may not appear as obvious fixed obstructions.<\/p>\n\n\n\n<p><strong>Q: After MINOCA, what are typical next steps in follow-up?<\/strong><br\/>\nFollow-up often includes confirming the final diagnosis, monitoring symptoms, and reassessing cardiac function when appropriate. Clinicians may also evaluate risk factors and consider cardiac rehabilitation or structured recovery planning depending on the mechanism and overall clinical picture. The specifics vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: Can someone return to normal activity or work after MINOCA?<\/strong><br\/>\nMany people can resume activities over time, but the timeline and restrictions depend on the underlying diagnosis, symptoms, ventricular function, and complications. Clinicians typically individualize return-to-activity guidance and may use rehabilitation programs to support a graded recovery.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MINOCA stands for **myocardial infarction with non-obstructive coronary arteries**. It is a **clinical syndrome (working diagnosis)** that looks like a heart attack but lacks a major coronary blockage on angiography. MINOCA is commonly encountered in **acute coronary syndrome** pathways in emergency and inpatient cardiology. It prompts clinicians to look for **alternative coronary and non-coronary mechanisms** of myocardial (heart muscle) injury.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-606","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=606"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/606\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}